Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.

Scandinavian journal of infectious diseases - 1 Jan 1995

Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G

Abstract excerpt

A total of 42 Swedish patients with biopsy-proven chronic hepatitis C virus (HCV) infection were treated with a natural human leucocyte alpha-interferon (HuIFN-alpha-Le), Alfanative (BioNative AB, Umeå, Sweden) in an open uncontrolled study. Two patients were withdrawn from treatment within 2 wee...

Topics

Adult
Aged
Alanine Transaminase
Antibody Formation
Antiviral Agents
Base Sequence
Enzyme-Linked Immunosorbent Assay
Female
Genotype
Hepacivirus
Hepatitis C
Hepatitis, Chronic
Humans
Interferon-alpha
Male
Middle Aged
Molecular Sequence Data
RNA, Viral

Source

Open in PubMed

Identifiers

PMID: 8658063

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8658063-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics